Clinical Trial

Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine

Name: Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine — clinical trial record (NCT07418229)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated February 18, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the safety of Sinovac RSV mRNA among participants aged ≥18 years

Trial Details

NCT Number	NCT07418229
Lead Sponsor	Sinovac Biotech Co., Ltd
Conditions	RSV, mRNA Vaccine
Enrollment	60 participants
Start Date	2026-03-09
Primary Completion	2026-06-30 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-18